APVO logo

Aptevo Therapeutics (APVO) EBITDA

Annual EBITDA

-$28.31 M
-$571.00 K-2.06%

December 31, 2023

Summary

Performance

1-Year Change

-2.06%

3-Year Change

-8.52%

5-Year Change

+42.54%

15-Year Change

+44.29%

APVO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.81%
APVO annual EBITDA is higher than 44.81% of companies in Healthcare sector

High & Low

All-time High

-$20.26 M

3-Year Low

-$28.31 M
APVO annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
APVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
APVO next annual earnings announcement is scheduled for Mar 5, 2025

OtherAPVOprofitabilitymetrics:

Annual Revenue

-
APVO annual revenue value is unknown

Annual Net Income

-$17.41 M
APVO annual net profit is -$17.41 million

Annual EBIT

-$28.88 M
APVO annual earnings before interest & taxes is -$28.88 million

Annual EPS

-$2311.76
APVO annual earnings per share is -$2311.76

Quarterly EBITDA

-$5.13 M
+$804.00 K+13.55%

September 30, 2024

Summary

Performance

3-Month Change

+13.55%

1-Year Change

+18.17%

3-Year Change

+18.17%

5-Year Change

+30.72%

APVO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.2%
APVO quarterly EBITDA is higher than 47.2% of companies in Healthcare sector

High & Low

All-time High

-$3.78 M

3-Year Low

-$8.03 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
APVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
APVO next earnings announcement is scheduled for Mar 5, 2025

OtherAPVOprofitabilitymetrics:

Quarterly Revenue

-
APVO quarterly revenue value is unknown

Quarterly Net Income

-$5.10 M
APVO quarterly net profit is -$5.10 million

Quarterly EBIT

-$5.21 M
APVO quarterly earnings before interest & taxes is -$5.21 million

Quarterly EPS

-$17.76
APVO quarterly earnings per share is -$17.76

TTM EBITDA

-$24.21 M
+$1.31 M+5.13%

September 30, 2024

Summary

Performance

3-Month Change

+5.13%

1-Year Change

+14.5%

3-Year Change

+14.5%

5-Year Change

+37.49%

APVO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.93%
APVO TTM EBITDA is higher than 45.93% of companies in Healthcare sector

High & Low

All-time High

-$10.51 M

3-Year Low

-$30.69 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
APVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
APVO next earnings announcement is scheduled for Mar 5, 2025

OtherAPVOprofitabilitymetrics:

TTM Revenue

-
APVO TTM revenue value is unknown

TTM Net Income

-$23.72 M
APVO TTM net profit is -$23.72 million

TTM EBIT

-$24.60 M
APVO TTM earnings before interest & taxes is -$24.60 million

TTM EPS

-$3598.31
APVO TTM earnings per share is -$3598.31

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$28.31 M
APVO annual EBITDA is -$28.31 million

Annual Net Income

-$17.41 M
APVO annual net profit is -$17.41 million

Annual Interest Expense

-
APVO annual interest expense value is unknown

Annual Income Tax

-
APVO annual income tax value is unknown

Annual D&A

$567.00 K
APVO annual depreciation & amortization is $567.00 thousand

APVO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.1%+18.2%+14.5%
3 y3 years-8.5%+18.2%+14.5%
5 y5 years+42.5%+30.7%+37.5%

APVO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-39.8%at low-35.5%+36.1%-27.2%+21.1%
5 y5-year-39.8%+26.9%-35.5%+36.1%-27.2%+37.5%
alltimeall time-39.8%+56.0%-35.5%+72.0%-130.3%+59.7%

Aptevo Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.13 M(-13.6%)
-$24.21 M(-5.1%)
Jun 2024
-
-$5.93 M(-13.7%)
-$25.52 M(-7.6%)
Mar 2024
-
-$6.88 M(+9.7%)
-$27.61 M(-2.5%)
Dec 2023
-$28.31 M(+2.1%)
-$6.27 M(-2.6%)
-$28.31 M(-4.2%)
Sep 2023
-
-$6.44 M(-19.8%)
-$29.57 M(-3.7%)
Jun 2023
-
-$8.03 M(+5.9%)
-$30.69 M(+2.5%)
Mar 2023
-
-$7.58 M(+0.7%)
-$29.95 M(+8.0%)
Dec 2022
-$27.74 M(+36.9%)
-$7.52 M(-0.5%)
-$27.74 M(+15.6%)
Sep 2022
-
-$7.56 M(+3.8%)
-$24.00 M(+14.9%)
Jun 2022
-
-$7.29 M(+35.7%)
-$20.89 M(+9.8%)
Mar 2022
-
-$5.37 M(+41.9%)
-$19.03 M(-6.0%)
Dec 2021
-$20.26 M(-22.4%)
-$3.78 M(-15.1%)
-$20.26 M(-11.7%)
Sep 2021
-
-$4.46 M(-17.8%)
-$22.95 M(-6.1%)
Jun 2021
-
-$5.42 M(-17.8%)
-$24.44 M(-4.2%)
Mar 2021
-
-$6.59 M(+1.8%)
-$25.52 M(-2.2%)
Dec 2020
-$26.09 M(-32.6%)
-$6.48 M(+8.9%)
-$26.09 M(-3.4%)
Sep 2020
-
-$5.95 M(-8.5%)
-$27.01 M(-15.5%)
Jun 2020
-
-$6.50 M(-9.3%)
-$31.98 M(-9.4%)
Mar 2020
-
-$7.17 M(-3.2%)
-$35.31 M(-8.8%)
Dec 2019
-$38.73 M
-$7.40 M(-32.2%)
-$38.73 M(-12.6%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$10.91 M(+11.0%)
-$44.31 M(-1.4%)
Jun 2019
-
-$9.83 M(-7.1%)
-$44.93 M(-4.3%)
Mar 2019
-
-$10.58 M(-18.5%)
-$46.94 M(-4.7%)
Dec 2018
-$49.27 M(-3.0%)
-$12.99 M(+12.6%)
-$49.27 M(-7.0%)
Sep 2018
-
-$11.53 M(-2.7%)
-$52.97 M(+4.9%)
Jun 2018
-
-$11.84 M(-8.3%)
-$50.52 M(-3.7%)
Mar 2018
-
-$12.91 M(-22.6%)
-$52.45 M(+3.2%)
Dec 2017
-$50.82 M(-21.1%)
-$16.68 M(+83.9%)
-$50.82 M(+0.5%)
Sep 2017
-
-$9.07 M(-34.1%)
-$50.55 M(-15.5%)
Jun 2017
-
-$13.77 M(+22.0%)
-$59.80 M(+3.1%)
Mar 2017
-
-$11.29 M(-31.2%)
-$57.99 M(-1.5%)
Dec 2016
-$64.40 M(+10.7%)
-$16.42 M(-10.4%)
-$58.84 M(-2.1%)
Sep 2016
-
-$18.32 M(+53.1%)
-$60.12 M(+10.9%)
Jun 2016
-
-$11.96 M(-1.5%)
-$54.20 M(-9.4%)
Mar 2016
-
-$12.14 M(-31.4%)
-$59.83 M(+2.8%)
Dec 2015
-$58.19 M(+17.6%)
-$17.69 M(+42.7%)
-$58.19 M(+43.7%)
Sep 2015
-
-$12.40 M(-29.5%)
-$40.50 M(+44.1%)
Jun 2015
-
-$17.59 M(+67.4%)
-$28.10 M(+167.4%)
Mar 2015
-
-$10.51 M
-$10.51 M
Dec 2014
-$49.47 M(-6.1%)
-
-
Dec 2013
-$52.69 M
-
-

FAQ

  • What is Aptevo Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Aptevo Therapeutics?
  • What is Aptevo Therapeutics annual EBITDA year-on-year change?
  • What is Aptevo Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Aptevo Therapeutics?
  • What is Aptevo Therapeutics quarterly EBITDA year-on-year change?
  • What is Aptevo Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Aptevo Therapeutics?
  • What is Aptevo Therapeutics TTM EBITDA year-on-year change?

What is Aptevo Therapeutics annual EBITDA?

The current annual EBITDA of APVO is -$28.31 M

What is the all time high annual EBITDA for Aptevo Therapeutics?

Aptevo Therapeutics all-time high annual EBITDA is -$20.26 M

What is Aptevo Therapeutics annual EBITDA year-on-year change?

Over the past year, APVO annual EBITDA has changed by -$571.00 K (-2.06%)

What is Aptevo Therapeutics quarterly EBITDA?

The current quarterly EBITDA of APVO is -$5.13 M

What is the all time high quarterly EBITDA for Aptevo Therapeutics?

Aptevo Therapeutics all-time high quarterly EBITDA is -$3.78 M

What is Aptevo Therapeutics quarterly EBITDA year-on-year change?

Over the past year, APVO quarterly EBITDA has changed by +$1.14 M (+18.17%)

What is Aptevo Therapeutics TTM EBITDA?

The current TTM EBITDA of APVO is -$24.21 M

What is the all time high TTM EBITDA for Aptevo Therapeutics?

Aptevo Therapeutics all-time high TTM EBITDA is -$10.51 M

What is Aptevo Therapeutics TTM EBITDA year-on-year change?

Over the past year, APVO TTM EBITDA has changed by +$4.11 M (+14.50%)